News · November 04, 2026, 18:31 UTC
CVS Health said on Wednesday, November 4, 2026, that it will split into two publicly traded companies by the first half of 2028, separating its retail pharmacy business from its health insurance and pharmacy benefits operations.
The announcement confirms a plan the Financial Times first reported on Tuesday, according to Yahoo Finance.
The restructuring unwinds a strategy that began with the 2007 Caremark merger and continued with the $69 billion acquisition of Aetna in 2018, CNN reported.
CVS Health shares fell 12% on the day, according to Yahoo Finance, even as the company reported third-quarter results that beat analyst expectations.
What happened
Under the plan, one company, to be named CVS Pharmacy, will hold roughly 9,000 retail pharmacies, the mail order pharmacy, the specialty drug business and MinuteClinic, CNN reported.
The other, called CVS Health in the interim, will comprise Aetna, Caremark and two businesses CVS acquired that provide primary care and in-home health evaluations to seniors.
“We’re basically taking what I believe is one great company and making it two,” CEO David Joyner said, according to Yahoo Finance.
On a call with analysts, Joyner said the move was not born of distress, citing healthy balance sheets and momentum in each business, Morningstar reported, citing an AlphaSense transcript.
The third-quarter numbers, released minutes before the split was confirmed, showed adjusted earnings per share of $2.09 against the $1.65 analysts expected, per Yahoo Finance.
Revenue was $108.4 billion, up about 5% from $102.9 billion a year earlier and ahead of the $104.8 billion FactSet estimate, Morningstar reported. The medical-benefit ratio came in at 91.3%, better than the 92.3% FactSet consensus, while same-store sales fell 0.6%.
Management raised its 2026 outlook to at least $8.20 in adjusted EPS and gave a first 2027 view of at least $8.65, Yahoo Finance reported. CVS said the cost of the split is already reflected in guidance and that dis-synergies can be managed.
The company did not announce any store closures, and CNN reported the split will not change how patients pay for prescriptions.
Analysis: Why it matters for investors
The breakup, if completed as planned, would reverse years of vertical integration in healthcare.
Mizuho analyst Ann Hynes wrote that the rationale was not fully clear but that the decision was likely driven by legislative and legal pressure on vertically integrated companies, particularly pharmacy benefit managers, and by a desire to unlock value in the insurance business, Morningstar reported.
Valuation comparisons may shape how the market prices the larger half. Cigna, which pairs Express Scripts with an insurer and no stores, trades at 9.3x forward earnings, while UnitedHealth trades at about 18x, according to Yahoo Finance.
CVS itself traded at 11x forward earnings at Tuesday’s close, near its 10x five-year average.
Yahoo Finance argued the breakup alone does not unlock much value and that the case for CVS still rests on Aetna’s margin recovery, which it said is running ahead of plan.
That is an analyst view, not a guarantee; the insurance segment’s adjusted operating income nearly tripled to $912 million in the quarter, but whether that pace holds is uncertain. Investors should weigh the execution risk of a transaction that will not close until the first half of 2028.
Who is affected
Customers are affected only indirectly, according to CNN: store operations and prescription costs are not slated to change, and no closures were announced.
Employees, suppliers and landlords of the retail arm would sit inside CVS Pharmacy, while Aetna, Caremark and the care businesses would fall under the interim CVS Health entity.

Investors bore the immediate impact, with the stock down 12% on November 4, 2026, per Yahoo Finance. Lawmakers and regulators focused on pharmacy benefit managers also have a stake, given the scrutiny of vertically integrated healthcare companies described by Morningstar.
Leerink Partners analyst Michael Cherny, who called the news “a complete shock,” wrote that the pharmacy business has performed well, so a standalone retail pharmacy may have a stronger outlook now, CNN reported.
What is still uncertain
The sources do not detail the debt allocation, tax treatment or final leadership of the two companies; the SEC registration will show what each company earns and owes, Yahoo Finance noted.
Whether the new CVS Health can narrow the medical-cost gap with UnitedHealth, 91.3% versus 88.4% of premiums in the third quarter, by 2028 has not been disclosed. Cigna’s drug-benefit margins, which fell 27% in the second quarter, could also affect how the market values the separated business.
Conclusion: What to watch next
Cigna reports this week, and its PBM margins may set the tone for how investors value the new CVS Health. The SEC registration filing will be the next hard data point on the finances of each entity. Until then, the market is pricing two companies whose details have not yet been made public.
brokertable.net has not reviewed the original announcement; details are based on reporting by Yahoo Finance, CNN and Morningstar.
Frequently Asked Questions
When will the CVS Health split be completed?
CVS Health said the separation into two public companies will close by the first half of 2028. The company said the cost is already included in its guidance.
What will each of the two companies contain?
CVS Pharmacy will hold roughly 9,000 retail pharmacies, mail order, specialty drugs and MinuteClinic. The interim CVS Health company will house Aetna, Caremark and two senior-care businesses.
How did CVS Health shares react?
Shares fell 12% on November 4, 2026, according to Yahoo Finance, despite a third-quarter beat. Adjusted EPS was $2.09 versus the $1.65 analysts expected.
Why is CVS splitting up?
Mizuho analyst Ann Hynes cited mounting legislative and legal pressure on vertically integrated companies, particularly PBMs, and a desire to unlock value in the insurance business. CEO David Joyner said the decision was not made out of distress.
Will the split affect stores or prescription prices?
CNN reported that no store closures were announced and that the split will not change how patients pay for prescriptions. The drugstore and Caremark already operate separately.
AI Notice: This article was created wholly or predominantly with the assistance of artificial intelligence and was published without human editorial review.
This article is for general information only and does not constitute investment advice. Always do your own research before making trading decisions.




